A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)

Clinical trial NCT01294709 · COMPLETED

Trial details

NCT number: NCT01294709
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Angina Pectoris Coronary Heart Disease Calcitonin Gene-related Peptide Receptor

Start date: 2008-02-12
Primary completion: 2009-02-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.